Fluimucil (acetylcysteine) (DrugBank: Acetylcysteine)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 193 | Prader-Willi syndrome | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2019-000735-61-NL (EUCTR) | 04/08/2020 | Treatment with N-acetylcysteine for skin picking in children and young adults with PWS | N- acetylcysteine treatment for skin picking in children and young adults with PWS: a randomized, controlled, cross-over trial. | Prader-Willi syndrome MedDRA version: 20.0;Level: PT;Classification code 10036476;Term: Prader-Willi syndrome;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Hormonal diseases [C19] | Trade Name: Fluimucil (acetylcysteine) Product Name: Fluimucil Product Code: R05CB01 | Dutch Growth Research Foundation | NULL | NA | Female: yes Male: yes | 35 | Phase 2;Phase 3 | Netherlands |